Renalytix plc
SEC CIK 1811115 · RNLX · last insider filing 2024-11-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Levangie Daniel J | Director | filed 2023 - 2023 |
| Mills Christopher | Director | filed 2023 - 2023 |
| Coste Catherine | Director | filed 2023 - 2023 |
| Parikh Chirag R. | Director | filed 2023 - 2023 |
| Fleming Fergus | Director · Chief Technical Officer | filed 2023 - 2023 |
| Mccullough James Renwick | Director · Chief Executive Officer | filed 2023 - 2023 |
| Scannell Timothy J | Director | filed 2023 - 2023 |
| Lium Erik | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jung Joel R | Interim Chief Financial Office | filed 2024 - 2024 |
| Doran Howard JR | Chief Business Officer | filed 2023 - 2023 |
| Mclain Thomas H | President | filed 2023 - 2023 |
| Sterling O. James | Chief Financial Officer | filed 2023 - 2023 |
| Donovan Michael J. | Chief Medical Officer | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.